EMEA-000239-PIP01-08-M03

Key facts

Invented name
Vibativ
Active substance
Telavancin (hydrochloride)
Therapeutic area
Infectious diseases
Decision number
P/0354/2017
PIP number
EMEA-000239-PIP01-08-M03
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
  • Treatment of nosocomial pneumonia
  • Treatment of complicated skin and soft tissue infections (cSSTI)
Route(s) of administration
Intravenous use
Contact for public enquiries
Theravance Biopharma Ireland Ltd.
Tel. +33 174882008
E-mail: marine.lafargue@quintilesims.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating